Boc-Lys(Tfa)-AMC

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP27619

CAS No:97885-44-4

Synonyms/Alias:Boc-L-Lys-MCA;Boc-Lys(Tfa)-AMC;CHEMBL402788;BDBM25149;CTK8F8298;ZINC49792062;(S)-tert-Butyl(1-((4-methyl-2-oxo-2H-chromen-7-yl)amino)-1-oxo-6-(2,2,2-trifluoroacetamido)hexan-2-yl)carbamate;97885-44-4;tert-butyl{(1S)-1-{[(4-methyl-2-oxo-2h-chromen-7-yl)amino]carbonyl}-5-[(trifluoroacetyl)amino]pentyl}carbamate;tert-butylN-[(1S)-1-[(4-methyl-2-oxo-2H-chromen-7-yl)carbamoyl]-5-(2,2,2-trifluoroacetamido)pentyl]carbamate

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C23H28F3N3O6
M.W/Mr.
499.49

Boc-Lys(Tfa)-AMC is a Boc-protected lysine derivative bearing an Nε-trifluoroacetyl (Tfa) protected side-chain and an AMC (7-amino-4-methylcoumarin) fluorogenic leaving group. This structure is designed for enzymatic substrate assays where cleavage releases the fluorescent AMC reporter, enabling sensitive monitoring of protease or peptidase activity under controlled in vitro conditions. The combination of orthogonally protected lysine functionalities and the AMC tag makes the compound a widely used reagent for assay development and mechanistic screening workflows that require consistent, reproducible fluorescence readouts.

1. Fluorogenic Protease Assays

Boc-Lys(Tfa)-AMC is used as a fluorogenic substrate in enzyme activity assays for lysine-targeting proteases and related peptidase systems, where enzymatic cleavage liberates AMC to generate a measurable fluorescence signal. Researchers in chemical biology and enzymology commonly employ this type of AMC-releasing substrate to compare relative activities across conditions, screen inhibitors, and validate assay performance using plate-reader compatible readouts. The lysine side-chain protection pattern supports controlled reactivity and helps maintain low background from non-enzymatic processes, while the AMC reporter provides a direct optical output for high-throughput workflows.

2. Protease Inhibitor Screening

Boc-Lys(Tfa)-AMC supports inhibitor discovery and optimization programs in academic and industrial research settings by providing a convenient fluorescence-based endpoint for monitoring protease inhibition. Medicinal chemistry groups and assay development teams use this reagent to generate concentration-response curves, rank inhibitor potency in early screens, and assess kinetic trends across compound series using standardized substrate turnover conditions. The AMC tag enables rapid measurement without requiring specialized derivatization steps, and the defined lysine-derived substrate motif helps align the assay readout with lysine-recognizing proteolytic events.

3. Enzyme Mechanism And Specificity Studies

Boc-Lys(Tfa)-AMC is also applied in mechanistic and specificity experiments where researchers probe how protease variants, buffer composition, or reaction parameters influence catalytic cleavage of lysine-containing substrates. Biochemistry and protein science laboratories use the fluorescence signal from AMC release to compare relative rates and to evaluate how changes in enzyme form or experimental conditions affect substrate processing. Because the reporter is generated only upon cleavage, the reagent supports practical discrimination between altered catalytic performance and assay artifacts, making it useful for method validation and experimental troubleshooting in fluorescence-based protease studies.

4. Fluorescence-Based Assay Development

Boc-Lys(Tfa)-AMC is frequently incorporated into assay development and validation workflows for fluorescence detection systems, including method setup for excitation/emission optimization, signal-to-background evaluation, and determination of working substrate concentrations. Analytical and screening teams use the reagent to establish robust assay windows and reproducible kinetics suitable for routine use in multiwell formats. The stable, pre-assembled AMC reporting group streamlines assay standardization, while the protected lysine framework helps reduce variability from uncontrolled side reactions during incubation, supporting consistent performance across day-to-day experiments.

Size
50 mg;250 mg;
InChI
1S/C23H28F3N3O6/c1-13-11-18(30)34-17-12-14(8-9-15(13)17)28-19(31)16(29-21(33)35-22(2,3)4)7-5-6-10-27-20(32)23(24,25)26/h8-9,11-12,16H,5-7,10H2,1-4H3,(H,27,32)(H,28,31)(H,29,33)/t16-/m0/s1
InChI Key
UFFVNATYYXBMGO-INIZCTEOSA-N
Canonical SMILES
CC1=CC(=O)OC2=C1C=CC(=C2)NC(=O)C(CCCCNC(=O)C(F)(F)F)NC(=O)OC(C)(C)C

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
cGMP Peptide ServiceCustom Conjugation ServicePeptide Modification ServicesPeptide CDMOPeptide Synthesis ServicesPeptide Analysis ServicesEpitope Mapping ServicesPeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers